Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial
Robert J Nash,1 Boris KG Azantsa,2 Hazel Sharp,1 Velmurugan Shanmugham31PhytoQuest Limited, Plas Gogerddan, Aberystwyth, Ceredigion, UK; 2Department of Biochemistry, University of Yaoundé I, Yaoundé, Cameroon; 3Samrat Research Institute, Bangalore, Karnataka, India Purpose: Ost...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/dceec4ff5b364774b883a1a0428abcdb |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:dceec4ff5b364774b883a1a0428abcdb |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:dceec4ff5b364774b883a1a0428abcdb2021-12-02T07:42:20ZEffectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial1178-1998https://doaj.org/article/dceec4ff5b364774b883a1a0428abcdb2018-10-01T00:00:00Zhttps://www.dovepress.com/effectiveness-of-cucumis-sativus-extract-versus-glucosamine-chondroiti-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Robert J Nash,1 Boris KG Azantsa,2 Hazel Sharp,1 Velmurugan Shanmugham31PhytoQuest Limited, Plas Gogerddan, Aberystwyth, Ceredigion, UK; 2Department of Biochemistry, University of Yaoundé I, Yaoundé, Cameroon; 3Samrat Research Institute, Bangalore, Karnataka, India Purpose: Osteoarthritis (OA) is an age-related disease caused by the wear and tear of the joints. Presently, there is no known cure for OA, but its management involves the use of high doses of pain killers and antiinflammatory agents with different side and dependency effects. Alternative management strategies involve the use of high doses of glucosamine-chondroitin (GC). This study was carried out to evaluate the efficacy of Q-Actin™, an aqueous extract of Cucumis sativus (cucumber; CSE) against GC in the management of moderate knee OA.Patients and methods: Overall, 122 patients (56 males and 66 females) aged between 40 and 75 years and diagnosed with moderate knee OA were included in this randomized double-blind, parallel-group clinical trial that took place in three different centers. The 180 day intervention involved two groups of 61 participants in each: the GC group, which received orally the generally prescribed dose of 1,350 mg of GC twice daily and the CSE group, which received orally10 mg twice daily of CSE. The Western Ontario McMaster Universities Osteoarthritis Index (WOMAC), Visual Analog scale, and Lequesne’s Functional Index were used to evaluate pain, stiffness, and physical function of knee OA in participants at baseline (Day 0) and on Days 30, 60, 90, 120, 150, and 180.Results: In the CSE group, the WOMAC score was decreased by 22.44% and 70.29% on Days 30 and 180, respectively, compared to a 14.80% and 32.81% decrease in the GC group. Similar trends were observed for all the other pain scores. No adverse effect was reported during the trial period.Conclusion: The use of 10 mg CSE, twice daily, was effective in reducing pain related to moderate knee OA and can be potentially used in the management of knee pain, stiffness, and physical functions related to OA.Keywords: Q-Actin™, cucumber, WOMAC, VAS, LFI, iminosugarNash RJAzantsa BKGSharp HShanmugham VDove Medical PressarticleQ-ActinTMCucumberWOMACVASLFIIminosugarGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 13, Pp 2119-2126 (2018) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Q-ActinTM Cucumber WOMAC VAS LFI Iminosugar Geriatrics RC952-954.6 |
| spellingShingle |
Q-ActinTM Cucumber WOMAC VAS LFI Iminosugar Geriatrics RC952-954.6 Nash RJ Azantsa BKG Sharp H Shanmugham V Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial |
| description |
Robert J Nash,1 Boris KG Azantsa,2 Hazel Sharp,1 Velmurugan Shanmugham31PhytoQuest Limited, Plas Gogerddan, Aberystwyth, Ceredigion, UK; 2Department of Biochemistry, University of Yaoundé I, Yaoundé, Cameroon; 3Samrat Research Institute, Bangalore, Karnataka, India Purpose: Osteoarthritis (OA) is an age-related disease caused by the wear and tear of the joints. Presently, there is no known cure for OA, but its management involves the use of high doses of pain killers and antiinflammatory agents with different side and dependency effects. Alternative management strategies involve the use of high doses of glucosamine-chondroitin (GC). This study was carried out to evaluate the efficacy of Q-Actin™, an aqueous extract of Cucumis sativus (cucumber; CSE) against GC in the management of moderate knee OA.Patients and methods: Overall, 122 patients (56 males and 66 females) aged between 40 and 75 years and diagnosed with moderate knee OA were included in this randomized double-blind, parallel-group clinical trial that took place in three different centers. The 180 day intervention involved two groups of 61 participants in each: the GC group, which received orally the generally prescribed dose of 1,350 mg of GC twice daily and the CSE group, which received orally10 mg twice daily of CSE. The Western Ontario McMaster Universities Osteoarthritis Index (WOMAC), Visual Analog scale, and Lequesne’s Functional Index were used to evaluate pain, stiffness, and physical function of knee OA in participants at baseline (Day 0) and on Days 30, 60, 90, 120, 150, and 180.Results: In the CSE group, the WOMAC score was decreased by 22.44% and 70.29% on Days 30 and 180, respectively, compared to a 14.80% and 32.81% decrease in the GC group. Similar trends were observed for all the other pain scores. No adverse effect was reported during the trial period.Conclusion: The use of 10 mg CSE, twice daily, was effective in reducing pain related to moderate knee OA and can be potentially used in the management of knee pain, stiffness, and physical functions related to OA.Keywords: Q-Actin™, cucumber, WOMAC, VAS, LFI, iminosugar |
| format |
article |
| author |
Nash RJ Azantsa BKG Sharp H Shanmugham V |
| author_facet |
Nash RJ Azantsa BKG Sharp H Shanmugham V |
| author_sort |
Nash RJ |
| title |
Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial |
| title_short |
Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial |
| title_full |
Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial |
| title_fullStr |
Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial |
| title_full_unstemmed |
Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial |
| title_sort |
effectiveness of cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial |
| publisher |
Dove Medical Press |
| publishDate |
2018 |
| url |
https://doaj.org/article/dceec4ff5b364774b883a1a0428abcdb |
| work_keys_str_mv |
AT nashrj effectivenessofcucumissativusextractversusglucosaminechondroitininthemanagementofmoderateosteoarthritisarandomizedcontrolledtrial AT azantsabkg effectivenessofcucumissativusextractversusglucosaminechondroitininthemanagementofmoderateosteoarthritisarandomizedcontrolledtrial AT sharph effectivenessofcucumissativusextractversusglucosaminechondroitininthemanagementofmoderateosteoarthritisarandomizedcontrolledtrial AT shanmughamv effectivenessofcucumissativusextractversusglucosaminechondroitininthemanagementofmoderateosteoarthritisarandomizedcontrolledtrial |
| _version_ |
1718399251260637184 |